Spectranetics

Spectranetics, now part of Philips, focuses on enhancing patient care through innovative solutions in lead management and vascular interventions. The company is committed to addressing significant health challenges, including managing lead infections and improving outcomes for patients with coronary artery disease.

With a values-driven culture, Spectranetics emphasizes collaboration and the pursuit of audacious goals such as eradicating restenosis and amputations. Their portfolio includes advanced devices for precise lead extraction and comprehensive vascular care, supporting diverse medical procedures to help patients return to the activities they love.

Generated from the website